オランザピンの世界市場レポート 2024年

オランザピンの市場規模は近年着実に成長しています。2023年の25億5,000万米ドルから2024年には26億2,000万米ドルへと、CAGR3.1％で拡大します。過去の期間に観察された成長は、精神疾患の罹患率の増加、意識の高まりと診断方法の改善、高齢者人口の増加、精神科治療の進歩、様々な適応症に対する医薬品の承認など、いくつかの要因に起因しています。

オランザピンの市場規模は、今後数年間で安定した成長が見込まれます。2028年にはCAGR2.8％で29億3,000万米ドルに成長します。予測期間中に予想される成長は、メンタルヘルスに対する意識の高まり、精神科治療薬における継続的な技術革新、メンタルヘルスに取り組む世界の取り組み、小児集団における利用率の増加、これらの治療薬とメンタルヘルスサービスとの統合によって促進されると予想されます。この期間に予測される注目すべき動向には、高齢患者向けに改良された製剤の開発、患者支援プログラムのイントロダクション、規制当局による監視の強化、デジタルヘルスソリューションの調査と開発、これらの薬剤の新たな適応症の研究への継続的な注力などが含まれます。

感情的な病気や精神的な健康問題の増加が予測されることから、オランザピン市場の拡大が見込まれます。非定型抗精神病薬であるこの薬剤は、統合失調症、双極性障害、うつ病などの治療に役立っており、メンタルヘルス治療ソリューションに対する需要の高まりに対応しています。2023年1月、米国薬物乱用・精神衛生管理局（Substance Abuse and Mental Health Services Administration）の報告書は、2021年に18歳以上の成人の約5.5％、1,410万人が深刻な精神疾患（SMI）に罹患したと報告したことを明らかにしました。なかでも、18歳から25歳の若年成人の割合が最も高く、次いで26歳から49歳、50歳以上となっています。このように感情的な病気や精神的な問題の有病率が高まっていることは、オランザピン市場の成長軌道を浮き彫りにしています。

高齢化人口の急増は、オランザピン市場の拡大に拍車をかける。統合失調症や双極性障害などの精神疾患は高齢者に多く、高齢者層はこれらの症状の管理にオランザピンを利用するようになっています。オランザピンは、幻覚、妄想、気分の変動などの症状に対応し、高齢者の精神的な健康の増進と生活の質の向上に大きく貢献します。2022年10月に発表された世界保健機関（WHO）の予測によると、60歳以上の世界人口は急増し、2050年には2倍の21億人に達すると予想されています。この人口動態の変化は、オランザピン市場における高齢化人口の増加の原動力を浮き彫りにしています。

2023年のオランザピン市場で最大の地域は北米でした。アジア太平洋は、オランザピンの世界市場レポートにおいて、予測期間中に最も急成長する地域となる見込みです。オランザピン市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のオランザピン市場、治療タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 単独療法
• 併用療法
• 世界のオランザピン市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 非経口
• 世界のオランザピン市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 統合失調症
• 双極性障害
• その他の用途
• 世界のオランザピン市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院
• 在宅ケア
• 専門クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のオランザピン市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のオランザピン市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オランザピン市場の競合情勢
• オランザピン市場の企業プロファイル
  • Aurobindo Pharma Ltd.
  • Teva Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Limited
  • Torrent Group

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Olanzapine Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on olanzapine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for olanzapine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The olanzapine market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Therapy Type: Monotherapy; Combinational Therapy
• 2) By Route Of Administration: Oral; Parenteral
• 3) By Application: Schizophrenia; Bipolar Disorder; Other Applications
• 4) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Companies Mentioned: Aurobindo Pharma Ltd.; Teva Pharmaceutical Industries Limited; Dr. Reddy's Laboratories Ltd.; Sun Pharmaceutical Industries Limited; Torrent Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Olanzapine, classified as an atypical antipsychotic, is prescribed for various mental health conditions such as schizophrenia, bipolar disorder, and depression linked to bipolar disorder. Its mechanism involves regulating specific brain chemicals, notably dopamine and serotonin.

Different types of olanzapine treatments include monotherapy and combination therapy. Monotherapy refers to the use of a single medication, such as olanzapine, or therapy to address specific conditions such as schizophrenia, bipolar disorder, and major depressive disorder. Olanzapine monotherapy involves solely using this medication without combining it with others. These treatments are typically administered orally or via parenteral routes and are utilized in hospitals, homecare settings, specialty clinics, and similar environments to manage conditions such as schizophrenia, bipolar disorder, and other related ailments.

The olanzapine market research report is one of a series of new reports from The Business Research Company that provides olanzapine market statistics, including olanzapine industry global market size, regional shares, competitors with an olanzapine market share, detailed olanzapine market segments, market trends and opportunities, and any further data you may need to thrive in the olanzapine industry. This olanzapine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The olanzapine market size has grown steadily in recent years. It will grow from $2.55 billion in 2023 to $2.62 billion in 2024 at a compound annual growth rate (CAGR) of 3.1%. The growth observed in the historical period can be attributed to several factors, including an increased incidence of mental health disorders, heightened awareness and improved diagnosis methods, a growing population of older adults, advancements in psychiatric treatments, and the approval of medications for various indications.

The olanzapine market size is expected to see steady growth in the next few years. It will grow to $2.93 billion in 2028 at a compound annual growth rate (CAGR) of 2.8%. The anticipated growth in the forecasted period is expected to be fueled by the rise in mental health awareness, ongoing innovations in psychiatric medications, global initiatives addressing mental health, increased utilization within the pediatric population, and the integration of these medications with mental health services. Notable trends projected for this period include the development of enhanced formulations tailored for elderly patients, the introduction of patient support programs, heightened regulatory scrutiny and monitoring, exploration and implementation of digital health solutions, and the sustained focus on researching new indications for these medications.

The projected increase in emotional illness and mental health issues is set to drive the expansion of the olanzapine market. This medication, an atypical antipsychotic, is instrumental in treating conditions such as schizophrenia, bipolar disorder, and depression-responding to the escalating demand for mental health treatment solutions. In January 2023, a report from the Substance Abuse and Mental Health Services Administration revealed staggering statistics approximately 5.5% of adults aged 18 or older equivalent to 14.1 million individuals reported experiencing serious mental illness (SMI) in 2021. Among these, the highest percentage was observed among young adults aged 18 to 25, followed by adults aged 26 to 49 and those aged 50 or older. This escalating prevalence of emotional illness and mental troubles underscores the growth trajectory of the olanzapine market.

The burgeoning aging population is poised to fuel the olanzapine market's expansion. With mental health conditions such as schizophrenia and bipolar disorder being more prevalent among older individuals, the aging demographic increasingly relies on olanzapine to manage these conditions. Addressing symptoms such as hallucinations, delusions, and mood fluctuations, olanzapine significantly contributes to enhancing mental well-being and improving the quality of life for the elderly. The World Health Organization's projection in October 2022 indicates a rapid increase in the global population of individuals aged 60 and older, expected to double by 2050, reaching 2.1 billion. This demographic shift highlights the driving force of the growing aging population on the olanzapine market.

A notable trend in the olanzapine market revolves around innovative combination therapies in mental health treatment. Companies are vigorously developing new treatment options to fortify their market positions. For example, in October 2021, Alkermes introduced Lybalvi, a combination therapy merging olanzapine-an atypical antipsychotic-with samidorphan, a mu-opioid receptor antagonist. This fusion aims to address schizophrenia and bipolar I disorder by combining olanzapine's therapeutic effects with samidorphan's opioid system modulation, specifically targeting symptoms such as hallucinations, delusions, disorganized thinking, and mood instability.

Major companies within the olanzapine market are adopting strategic partnerships to introduce olanzapine as the inaugural long-acting drug with a favorable safety profile. Strategic alliances, such as the collaboration between Teva Pharmaceutical Industries Ltd. and Royalty Pharma plc in November 2023, aim to expedite the clinical research program for Teva's olanzapine LAI (TEV-'749). This once-monthly subcutaneous long-acting injection of olanzapine, currently in Phase 3 for schizophrenia treatment, represents a significant milestone in advancing treatment options within the market.

In April 2023, Cheplapharm Arzneimittel GmbH, a Germany-based pharmaceutical company engaged in branded drugs, medical products, supplements, and cosmetics, acquired worldwide commercial rights for Zyprexa from Eli Lilly and Company for an undisclosed amount. Through this acquisition Cheplapharm strengthened its portfolio in the therapeutic area of the central nervous system. Eli Lilly and Company is a US-based pharmaceutical company engaged in olanzapine medications.

Major companies operating in the olanzapine market report are Aurobindo Pharma Ltd., Teva Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Limited, Torrent Group, Apotex Inc., Novartis AG, Mylan N.V., Alkermes Inc., Viatris Inc., Pfizer Inc., Zydus Cadila Healthcare Ltd., Endo International plc, Lupin Limited, Cipla Inc., Eli Lilly and Company, Zhejiang Langhua Pharmaceutical Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Bristol-Myers Squibb Company, Sandoz International GmbH, Changzhou Huasheng Pharmaceutical Co. Ltd., Par Pharmaceutical, Jubilant Pharmova Limited, Hansoh Pharmaceutical, AstraZeneca plc, Olanzapine API Manufacturers, Torrent Pharmaceuticals, Egis Pharmaceuticals plc, Actavis Group hf., Hexal AG

North America was the largest region in the olanzapine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global olanzapine market report during the forecast period. The regions covered in the olanzapine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the olanzapine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The olanzapine market consists of sales of branded and generic olanzapine medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Olanzapine Market Characteristics

3. Olanzapine Market Trends And Strategies

4. Olanzapine Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Olanzapine Market Size and Growth

• 5.1. Global Olanzapine Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Olanzapine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Olanzapine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Olanzapine Market Segmentation

• 6.1. Global Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Monotherapy
• Combinational Therapy
• 6.2. Global Olanzapine Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• 6.3. Global Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Schizophrenia
• Bipolar Disorder
• Other Applications
• 6.4. Global Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users

7. Olanzapine Market Regional And Country Analysis

• 7.1. Global Olanzapine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Olanzapine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Olanzapine Market

• 8.1. Asia-Pacific Olanzapine Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Olanzapine Market

• 9.1. China Olanzapine Market Overview
• 9.2. China Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Olanzapine Market

• 10.1. India Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Olanzapine Market

• 11.1. Japan Olanzapine Market Overview
• 11.2. Japan Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Olanzapine Market

• 12.1. Australia Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Olanzapine Market

• 13.1. Indonesia Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Olanzapine Market

• 14.1. South Korea Olanzapine Market Overview
• 14.2. South Korea Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Olanzapine Market

• 15.1. Western Europe Olanzapine Market Overview
• 15.2. Western Europe Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Olanzapine Market

• 16.1. UK Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Olanzapine Market

• 17.1. Germany Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Olanzapine Market

• 18.1. France Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Olanzapine Market

• 19.1. Italy Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Olanzapine Market

• 20.1. Spain Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Olanzapine Market

• 21.1. Eastern Europe Olanzapine Market Overview
• 21.2. Eastern Europe Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Olanzapine Market

• 22.1. Russia Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Olanzapine Market

• 23.1. North America Olanzapine Market Overview
• 23.2. North America Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Olanzapine Market

• 24.1. USA Olanzapine Market Overview
• 24.2. USA Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Olanzapine Market

• 25.1. Canada Olanzapine Market Overview
• 25.2. Canada Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Olanzapine Market

• 26.1. South America Olanzapine Market Overview
• 26.2. South America Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Olanzapine Market

• 27.1. Brazil Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Olanzapine Market

• 28.1. Middle East Olanzapine Market Overview
• 28.2. Middle East Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Olanzapine Market

• 29.1. Africa Olanzapine Market Overview
• 29.2. Africa Olanzapine Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Olanzapine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Olanzapine Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Olanzapine Market Competitive Landscape And Company Profiles

• 30.1. Olanzapine Market Competitive Landscape
• 30.2. Olanzapine Market Company Profiles
  • 30.2.1. Aurobindo Pharma Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Teva Pharmaceutical Industries Limited
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Dr. Reddy's Laboratories Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sun Pharmaceutical Industries Limited
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Torrent Group
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Olanzapine Market Competitive Benchmarking

32. Global Olanzapine Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Olanzapine Market

34. Olanzapine Market Future Outlook and Potential Analysis

• 34.1 Olanzapine Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Olanzapine Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Olanzapine Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer